A COVID-19 vaccine needs the public's trust - and it's risky to cut corners on clinical trials, as Russia is
The Conversation : Science + Technology, 2020-08-122021. This work is published under https://creativecommons.org/licenses/by-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Digital Resources/Online E-Resources